These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 974819)

  • 1. [Effect of d-lysergic acid (LSD) diethylamide on the ulcerogenic effect of phenylbutazone (author's transl)].
    Kohút A; Nicák A; Neuschl J
    Bratisl Lek Listy; 1976 May; 65(5):517-21. PubMed ID: 974819
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of vagotomy and lysergic acid diethylamide (LSD) on ulcerogenic action of phenylbutazone and reserpine in rats with regard to the role of 5-hydroxytryptamine (author's transl)].
    Kohút A; Nicák A
    Bratisl Lek Listy; 1977 Sep; 68(3):336-43. PubMed ID: 912454
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of prostaglandin E1 on the ulcerogenic action of phenylbutazone in rats of different age].
    Kohút A; Nicák A
    Cesk Gastroenterol Vyz; 1977 Oct; 31(7):465-9. PubMed ID: 597874
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of the ulcerogenic effects of phenylbutazone and indomethacin].
    Valentík M; Visnovský P
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):494-500. PubMed ID: 367607
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The therapy with lsd in homosexual males and transsexual females (author's transl)].
    Sípová I
    Cas Lek Cesk; 1974 Nov; 113(48):1491-3. PubMed ID: 4434423
    [No Abstract]   [Full Text] [Related]  

  • 7. [The relationship between the levels of calcium on the stomach wall and in the blood and ulcerogenic effect of phenylbutazone and reserpine in intact, adrenalectomized and vagotomized rats of various age (author's transl)].
    Neuschl J; Kohút A; Nicák A
    Cesk Gastroenterol Vyz; 1978 Mar; 32(2):85-90. PubMed ID: 657308
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of amitriptyline on the ulcerogenic action of phenylbutazone and reserpine with respect to calcium levels in the stomach wall and blood in rats of different ages (author's transl)].
    Neuschl J; Kohút A
    Bratisl Lek Listy; 1979 Feb; 71(2):173-8. PubMed ID: 427612
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mescaline, lysergic acid diethylamide (LSD 25) & menstruation].
    SALERNO EV; TALLAFERRO A
    Sem Med; 1957 Jan; 110(2):47-8; passim. PubMed ID: 13421863
    [No Abstract]   [Full Text] [Related]  

  • 10. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 11. [Side-effects of phenylbutazone].
    Boixet EB
    Rev Esp Reum Enferm Osteoartic; 1966 Oct; 11(8):44-55. PubMed ID: 5998010
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gast roduodenal complications of steroid and phenylbutazone therapy from the surgical viewpoint].
    Teutsch W
    Zentralbl Chir; 1968 Jul; 93(27):926-35. PubMed ID: 5666600
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic trial of lysergic Acid diethylamide (LSD) and thioridazine in chronic schizophrenia.
    Shirvaikar RV; Kelkar YW
    Neurol India; 1966; 14(2):97-101. PubMed ID: 5330728
    [No Abstract]   [Full Text] [Related]  

  • 15. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The us of LSD (d-lysergic acid diethylamide) in the therapy of children (a brief review).
    Abramson HA
    J Asthma Res; 1967 Dec; 5(2):139-43. PubMed ID: 4865578
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoradiographic studies on the possibility of influencing 3H-leucine incorporation rates in different areas of rat brain by LSD (author's transl)].
    Gatzke HD
    Arzneimittelforschung; 1977 Jul; 27(7):1399-403. PubMed ID: 578461
    [No Abstract]   [Full Text] [Related]  

  • 19. Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials.
    Krebs TS; Johansen PØ
    J Psychopharmacol; 2012 Jul; 26(7):994-1002. PubMed ID: 22406913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastroduodenal ulcer of medicational origin].
    Debray C; Duret P
    Sem Ther; 1968 Feb; 44(2):71-4. PubMed ID: 5744006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.